Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Oncology|May 29, 2024
Progression-free survival estimation of docetaxel-based second-line treatment for advanced non-small cell lung cancer: a pooled analysis from 18 randomized control trialsChaithra N, Anisha Jain, Sahana C, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 15, 2023
Evaluation of codon usage patterns and molecular evolution dynamics in Japanese encephalitis virus: An integrated bioinformatics approachKuralayanapalya Puttahonnappa Suresh, Uma Bharathi Indrabalan, Bhargav Shreevatsa, et al.
Frontiers in Oncology|January 6, 2022
Corrigendum: Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling PathwayAnisha S Jain, Ashwini Prasad, Sushma Pradeep, et al.
Scientific Reports|December 2, 2024
Gaining molecular insights towards inhibition of foodborne fungi Aspergillus fumigatus by a food colourant violacein via computational approachR Sindhu, Smitha S Bhat, Jiraporn Sangta, et al.
Frontiers in Chemistry|February 20, 2025
Exploring precision therapeutics: computational design of antisense oligonucleotides targeting AXL gene transcripts in multiple sclerosis treatment managementBhargav Shreevatsa, Abhigna Nagaraj, Chandan Dharmashekar, et al.
Frontiers in Oncology|October 25, 2021
Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling PathwayAnisha S Jain, Ashwini Prasad, Sushma Pradeep, et al.
Molecules (Basel, Switzerland)|February 11, 2023
Evaluating the Antimicrobial and Anti-Hemolytic Activity of Synthesized Pseudopeptide against <i>Leptospiral</i> Species: In Silico and In Vitro ApproachChandan Dharmashekar, Bhargav Shreevatsa, Anisha S Jain, et al.
Frontiers in Oncology|September 14, 2023
Cell cycle arrest and apoptotic studies of <i>Terminalia chebula</i> against MCF-7 breast cancer cell line: an <i>in vitro</i> and <i>in silico</i> approachPruthvish Reddy, Sushma Pradeep, Gopinath S M, et al.
Frontiers in Oncology|November 13, 2025
Repurposing risperidone as an anti-angiogenic agent for triple-negative breast cancer: a computational to <i>in ovo</i> investigationAnisha Jain, Anil Kumar Belagal Motatis, Chandan Dharmashekar, et al.
Pageof 2